[1] Feng HYF, Zhang HJ, Ma C, Zhang HN, Yin DP, Fang H. National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis. Lancet Reg Health West Pac 2023;32:100639. http://dx.doi.org/10.1016/j.lanwpc.2022.100639.
[2] Ministry of Health of People’s Republic of China. Notice of the General Office of the Ministry of Health on the printing and distribution of the national work specification for the management of information reporting related to public health emergencies (trial). 2006. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=31353. [2023-4-26] (In Chinese)
[3] Chen Y, Leng KK, Lu Y, Wen LH, Qi Y, Gao W, et al. Epidemiological features and time-series analysis of influenza incidence in urban and rural areas of Shenyang, China, 2010-2018. Epidemiol Infect 2020;148:e29. http://dx.doi.org/10.1017/S0950268820000151.
[4] Schaffer AL, Dobbins TA, Pearson SA. Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions. BMC Med Res Methodol 2021;21(1):58. http://dx.doi.org/10.1186/s12874-021-01235-8.
[5] Liu QY, Liu XD, Jiang BF, Yang WZ. Forecasting incidence of hemorrhagic fever with renal syndrome in China using ARIMA model. BMC Infect Dis 2011;11:218. http://dx.doi.org/10.1186/1471-2334-11-218.
[6] Liu AP, Sun TT. Meta-analysis of varicella vaccine coverage among Chinese children. Chin J Vaccines Immun 2017;23(6):698-704. https://d.wanfangdata.com.cn/periodical/zgjhmy201706022. (In Chinese)
[7] Leung J, Lopez AS, Marin M. Changing epidemiology of varicella outbreaks in the United States during the varicella vaccination program, 1995-2019. J Infect Dis 2022;226(S4):S400 − 6. http://dx.doi.org/10.1093/infdis/jiac214.
[8] Chen YW, Ma R, Zhang YY, Li XD, Yin DP. Effects of varicella vaccine time of first dose and coverage of second dose — Beijing and Ningbo, China, 2012–2018. China CDC Wkly 2020;2(36):696 − 9. http://dx.doi.org/10.46234/ccdcw2020.136.
[9] Zhao D, Suo LD, Lu L, Pan JB, Pang XH, Yao W. Effect of earlier vaccination and a two-dose varicella vaccine schedule on varicella incidence — Beijing Municipality, 2007–2018. China CDC Wkly 2021;3(15):311 − 5. http://dx.doi.org/10.46234/ccdcw2021.085.
[10] Ma C, Li JH, Wang N, Wang YM, Song YD, Zeng X, et al. Prioritization of vaccines for inclusion into China’s expanded program on immunization: evidence from experts’ knowledge and opinions. Vaccines 2022;10(7):1010. http://dx.doi.org/10.3390/vaccines10071010.
[11] Liu L, Luan RS, Yin F, Zhu XP, Lü Q. Predicting the incidence of hand, foot and mouth disease in Sichuan Province, China using the ARIMA model – CORRIGENDUM. Epidemiol Infect 2016;144(1):152. http://dx.doi.org/10.1017/S0950268815001582.
[12] Qi BG, Liu NK, Yu SC, Tan F. Comparing COVID-19 case prediction between ARIMA model and compartment model - China, December 2019–April 2020. China CDC Wkly 2022;4(52):1185 − 8. http://dx.doi.org/10.46234/ccdcw2022.239.
[13] Raycheva R, Kevorkyan A, Stoilova Y. Stochastic modelling of scalar time series of varicella incidence for a period of 92 years (1928-2019). Folia Med (Plovdiv) 2022;64(4):624 − 32. http://dx.doi.org/10.3897/folmed.64.e65957.